The currently marketed 23-valent pneumococcal polysaccharide vaccine provides large serotype coverage at a relatively low cost. However, it is not efficacious in young children. Pneumococcal conjugate vaccines (PCVs) are highly effective in preventing invasive disease in infants and young children, with...
The standard schedule specifies eligibility for doses at 6, 10, and 14 weeks of age. The participants in each alternative schedule cluster who are assigned to the measurement of immunogenicity endpoints are further assigned to receive the YF vaccine co-administered at 9 months of age with the ...
vaccine (ˈvæksiːn) n 1.(Medicine) a suspension of dead, attenuated, or otherwise modified microorganisms (viruses, bacteria, or rickettsiae) for inoculation to produce immunity to a disease by stimulating the production of antibodies ...
Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy. Pneumococcal (Pnc) carriage is associated with pneumococcal diseases. Breast feeding and maternal vaccination may be a useful approach to prevent pneumococ... Lopes, Claudia R.C.,EN ...
Brown A. Prevnar: A pneumococcal conjugate vaccine for infants and young children. Issues in Emerging Health Technologies Issue 14. Ottawa, ON: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. Burgess L, Southern KW. Pneumococcal vaccines for cystic fibrosis. Cochrane ...
Rodgers. (2011) Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil. Vaccine /... AL Andrade,R Oliveira,MA Vieira,... - 《Vaccine》 被引量: 76发表: 2012年 Pneumococcal vaccination in children at risk of developing rec...
Why should one receive the pneumococcal vaccine? Invasive pneumococcal disease is usually more serious in infants and the elderly. Pneumococcal conjugate vaccines are effective in preventing severe invasive pneumococcal infections (such as meningitis, bacteremic pneumonia and septicemia) caused by the sero...
Ortqvist A, Henckaerts I, Hedlund J, Poolman J (2007) Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly. Vaccine 25:2445–2450 PubMed CAS Google Scholar Millar EV, O’Brien KL, Bronsdon MA, Madore D, Hackell JG...
In recent years, the most important advance in the prevention of pneumococcal infections in the elderly has been the introduction of a 7-valent conjugate pneumococcal vaccine (CPV) as a routine vaccination for infants. In addition to dramatically reducing invasive infection in children, CPV has ...
Use of Pneumococcal Vaccine for Prevention of Recurrent Acute Otitis Media in Infants in Boston The efficacy of pneumococcal polysaccharide vaccine for children suffering from recurrent acute otitis media (AOM) was determined by administration, in a r... DW Teele,JO Klein,B Lorna,... - 《Rev ...